Sandra Levy
ARTICLES BY THIS AUTHOR
- 6/10/2020
Pfizer gets FDA OK for biosimilar Neulasta
Pfizer's Nyvepria helps to reduce the chance of infection due to a low white blood cell count in people with non-myeloid cancer who receive anti-cancer medicines, including chemotherapy. - 6/10/2020
CVS Health opens 10 drive-thru COVID-19 test sites in Kansas
CVS Health's new COVID-19 test sites at select CVS Pharmacy drive-thru locations across Kansas will help enable the retailer's goal of processing up to 1.5 million tests per month nationwide. - 6/9/2020
Dr. Reddy’s acquires Wockhardt's generics business divisions
Dr. Reddy's is acquiring Wockhardt's branded generics, which include respiratory, neurology, VMS, dermatology, gastroenterology, pain and vaccines. - 6/9/2020
Teva releases generic Afinitor
Novartis is launching generic Afinitor tablets in dosage strengths of 2.5 mg, 5 mg and 7.5 mg. - 6/8/2020
Colorado passes law authorizing pharmacist PrEP, PEP prescribing
Pending approval by Colorado Gov. Jared Polis, House Bill 20-1061, which has passed the Colorado House and Senate, will authorize pharmacists to prescribe and dispense HIV PrEP or PEP medications. - 6/8/2020
Leucadia launches generic Migranal
Leucadia’s dihydroergotamine mesylate nasal spray is the first generic of Bausch Health’s Migranal. - 6/8/2020
Hy-Vee to donate $1M, volunteer hours to orgs supporting racial unity, equality
Hy-Vee’s donation in support of racial equality will be funded through the company’s philanthropic One Step program. - 6/8/2020
MaxorPlus selects Hy-Vee’s Amber Pharmacy for dispensing to transplant patients
MaxorPlus clients can choose Amber Pharmacy’s service model for members with organ transplant medication needs. - 6/7/2020
AstraZeneca, Gilead reportedly in early merger talks
An AstraZeneca merger with Gilead — which Bloomberg reported is being preliminarily discussed by the companies — would be a record-breaking deal in health care. - 6/7/2020
McKesson taps Tom Rodgers to lead strategy, business development
Tom Rodgers is McKesson's new executive vice president and chief strategy and business development officer, succeeding Bansi Nagji, who stepped down March 31.
